Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Recruiting
Observational Study
Bladder Cancer
Urothelial Carcinoma (UC)
Muscle Invasive Bladder Cancer (MIBC)
Non Muscle Invasive Bladder Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Oslo University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Newly diagnosed bladder cancer on cystoscopy
* Planned TURBT or cystectomy within 6 weeks
* Eligible for both CT and MRI within 6 weeks
* Written informed consent provided
Exclusion Criteria:
* Contraindications to MRI or iodinated contrast media
* Prior tre…
Contacts